<?xml version="1.0" encoding="UTF-8"?>
<p>While some preparations have been claimed to be specifically active, some commonly used medicinal plants are assessed here, especially those on the WHO list of selected medicinal plants, as adjuvant treatments. For example, 
 <xref rid="B229" ref-type="bibr">Hensel et al. (2020)</xref>, in their recent work, state that extracts prepared with 
 <italic>Echinacea</italic> species (Asteraceae) have an important role with the immune system due to their alkylamide interacting with the cannabinoid receptors (
 <xref rid="B229" ref-type="bibr">Hensel et al., 2020</xref>). Additionally, curcumin, the main constituent in 
 <italic>Curcuma longa</italic> L. (Zingiberaceae), is suggested as a potential clinical option for the treatment of SARS-CoV-2 infection, due to its action in several steps of a viral infection such as protease inhibition, cellular signalling pathways modulation, among others (
 <xref rid="B531" ref-type="bibr">Zahedipour et al., 2020</xref>)
</p>
